Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
April 7, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 7, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
April 7, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 7, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

View HTML
March 30, 2022 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 18, 2022 CT ORDER

CT ORDER

View HTML
March 2, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2022 4

Statement of changes in beneficial ownership of securities

View HTML
March 2, 2022 4

Statement of changes in beneficial ownership of securities

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us